Clinical Trials
14
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (14 trials with phase data)• Click on a phase to view related trials
Standardized Procedure for Intracranial Drug-Eluting Stenting in the Treatment of Intracranial Atherosclerotic Stenosis
- Conditions
- Intracranial Atherosclerotic Stenosis
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-04-01
- Lead Sponsor
- Sino Medical Sciences Technology Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT06857058
- Locations
- 🇨🇳
The first affiliated hospital of zhengzhou university, Zhengzhou, China
Comparison Three Vs Six Months of Dual Anti-platelet Therapy After Sirolimus-eluting Stent Implantation
- Conditions
- Intracranial ArteriosclerosisIntracranial Artery StenosisDrug-Eluting Stents
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-04-01
- Lead Sponsor
- Sino Medical Sciences Technology Inc.
- Target Recruit Count
- 478
- Registration Number
- NCT06857045
- Locations
- 🇨🇳
The Fourth Affiliated Hospital of China Medical University, Ha'erbin, China
A Registry Study of Intracranial Atherosclerotic Stenosis Treatment by Intracranial Drug-eluting Stenting in China
- Conditions
- Intracranial Artery StenosisStenosis ArteryDrug-Eluting StentsIntracranial Arteriosclerosis
- First Posted Date
- 2023-01-20
- Last Posted Date
- 2025-04-01
- Lead Sponsor
- Sino Medical Sciences Technology Inc.
- Target Recruit Count
- 1000
- Registration Number
- NCT05692882
- Locations
- 🇨🇳
First People's Hospital of Chenzhou, Chenzhou, China
🇨🇳Ganzhou People's Hospital, Ganzhou, China
🇨🇳Jinhua Municipal Central Hospital, Jinhua, China
Compare the Effectiveness and Safety of Two Different Kinds of Cutting Balloon in Coronary Artery Disease
- Conditions
- Coronary StenosisCoronary Artery StenosisIn-stent Restenosis
- First Posted Date
- 2022-08-22
- Last Posted Date
- 2024-03-04
- Lead Sponsor
- Sino Medical Sciences Technology Inc.
- Target Recruit Count
- 136
- Registration Number
- NCT05509296
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, China
🇨🇳Peking University Third Hospital, Beijing, China
🇨🇳Kaifeng Central Hospital, Kaifeng, China
A Study to Evaluate the Impact of 11-month Ticagrelor Monotherapy Following One-month DAPT After PCI
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2021-08-20
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Sino Medical Sciences Technology Inc.
- Registration Number
- NCT05015699
- Prev
- 1
- 2
- 3
- Next